ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,993Medicare Part D Prescriptions Filled, Including Refills

Rank: 236 out of 1677

$681K Total Retail Price of All Prescriptions

Rank: 190 out of 1677

574 Patients Receiving at Least One Drug in Part D
61%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 574 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 574 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 6,980 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 660 466 1 2
LISINOPRIL 620 413 2 3
SIMVASTATIN 568 361 3 1
HYDROCHLOROTHIAZIDE 493 318 4 9
NEXIUM 462 305 5 19
TRAMADOL HCL 357 254 6 16
METFORMIN HCL 345 192 7 7
CRESTOR 304 177 8 28
METOPROLOL SUCCINATE 296 153 9 23
FUROSEMIDE 255 144 10 8
TOPROL XL 249 179 11 215
HYDROCODONE-ACETAMINOPHEN 232 80 S3 12 4
GABAPENTIN 204 99 13 11
DOXAZOSIN MESYLATE 199 133 14 90
LOSARTAN POTASSIUM 193 107 15 25
FLUTICASONE PROPIONATE 185 86 16 29
OMEPRAZOLE 177 90 17 6
ALLOPURINOL 171 104 18 31
LANTUS 160 64 19 44
LOSARTAN-HYDROCHLOROTHIAZIDE 159 82 20 42
XOPENEX HFA 155 69 21 248
LEVOTHYROXINE SODIUM 155 102 21 5
CLONIDINE HCL 137 78 23 36
GLIMEPIRIDE 127 67 24 33
TRIAMTERENE-HYDROCHLOROTHIAZID 121 79 25 213
RANITIDINE HCL 113 68 26 18
SYMBICORT 106 38 27 150
COZAAR 102 78 10 28 254
PRAVASTATIN SODIUM 95 52 29 10
CARVEDILOL 93 64 30 20
SERTRALINE HCL 91 54 31 26
AMITRIPTYLINE HCL 87 27 R 32 63
POTASSIUM CHLORIDE 85 39 33 14
CLOPIDOGREL 84 45 34 32
ATENOLOL 83 43 35 21
GLIPIZIDE XL 82 49 36 123
NOVOLIN 70-30 81 51 37 155
METOPROLOL TARTRATE 80 58 38 12
IBUPROFEN 79 34 39 83
TRIAMTERENE-HCTZ 79 52 39 61
INSULIN SYRINGE 79 29 39 72
CYCLOBENZAPRINE HCL 74 17 R 42 52
PLAVIX 73 45 43 47
GLIPIZIDE ER 72 65 44 78
ISOSORBIDE MONONITRATE ER 70 48 45 73
NOVOLOG 67 23 46 117
SPIRONOLACTONE 66 40 47 88
HYDROXYZINE HCL 65 29 R 48 148
ZOLPIDEM TARTRATE 63 22 49 15
COLCRYS 57 29 50 141
NAPROXEN 55 25 51 87
VENTOLIN HFA 54 14 52 89
TRAZODONE HCL 53 22 53 37
FINASTERIDE 52 41 54 130
PROAIR HFA 51 34 55 50
ATROVENT HFA 50 20 56 332
PREDNISONE 50 28 56 40
ADVAIR DISKUS 50 19 56 54
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 15, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.